Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency

Haematologica

Volumn 86, Issue 6, 2001, Pages 640-645

  Berrettini, M ^a   Mariani, G ^a   Schiavoni, M ^a   Rocino, A ^a   Di Paolantonio, T ^a   Longo, G ^a   Morfini, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Activated recombinant factor VII; Factor VII; Factor VII congenital deficiency; Pharmacokinetics

Indexed keywords

ACENOCOUMAROL; ANTITHROMBIN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; FEMALE; HEMOPHILIA; HEREDITY; HUMAN; MALE; MEAN RESIDENCE TIME;

ADULT; CROSS-OVER STUDIES; FACTOR VII; FACTOR VII DEFICIENCY; FAMILY HEALTH; FEMALE; HUMANS; MALE; RECOMBINANT PROTEINS;

EID: 0034950331     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tissue factor and hemostasis
2. Activation of Factor VII bound to tissue factor: A key early step in the tissue factor pathway of blood coagulation
3. Factor VII deficiency
4. Factor VII congenital deficiency. Clinical picture and classification of the variants
5. Hereditary factor VII deficiency: Heterogeneity defined by combined functional and immunochemical analysis
6. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency
7. Selection of replacement therapy for patients with severe factor VII deficiency
8. Factor VII half-life after transfusion of a steam-treated prothrombin complex concentrate in a patient with homozygous factor VII deficiency
9. Treatment of congenital factor VII deficiency with a new concentrate
10. Activated factor VII: Presence in factor IX concentrates and persistence in the circulation after infusion
11. Successful use of recombinant factor VIIa in patients with severe haemophilia A during synovectomy
12. Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders
13. Recombinant factor VIIa for the treatment of congenital factor VII deficient patients
14. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies
15. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study
16. The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized ratio above 2
17. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
18. Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor
19. Platelet activity of high-dose factor VIIa is independent of tissue factor
20. Pharmacokinetics of recombinant factor VIIa in the rat: A comparison of bio-, immuno- and isotope assays
21. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa
22. Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol
23. Clinical aspects of congenital factor VII deficiency
24. A simple chromogenic substrate assay of tissue factor pathway inhibitor activity in plasma and serum
25. The design and analysis of half-life and recovery studies for factor VIII and factor IX
26. Pharmacokinetics of a new heat-treated concentrate of factor VIII estimated by model-independent methods
27. Characteristics of various factor VIII concentrates used in treatment of haemophilia A
28. In vivo recovery of factor VIII following transfusion: A survey of recent data and publications to assess the influence of standards used for potency assignment
29. Pharmacokinetics of recombinant activated factor VII (rFVIIa)
30. Inhibition of thrombin generation by the zymogen factor VII: Implications for the treatment of hemophilia A by factor VIIa
31. The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen
32. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo